Entera Bio (ENTX) Institutional Ownership $1.94 -0.03 (-1.28%) As of 12:26 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Entera Bio (NASDAQ:ENTX)CurrentInstitutional OwnershipPercentage14.11%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$5.16MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$66.36K Get ENTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Entera Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ENTX Institutional Buying and Selling by Quarter Entera Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025 Parkman Healthcare Partners LLC439,632$747K0.1%+6.3%0.968% 5/13/2025 HighTower Advisors LLC18,140$31K0.0%+53.3%0.040% 2/18/2025 Knoll Capital Management LLC5,881,879$12.47M8.0%+51.5%16.439% 2/14/2025 Schonfeld Strategic Advisors LLC632,311$1.34M0.0%-2.5%1.767% 2/14/2025 Northern Trust Corp212,483$450K0.0%N/A0.594% 1/22/2025 Perigon Wealth Management LLC145,843$325K0.0%N/A0.408% 11/15/2024 Parkman Healthcare Partners LLC411,076$781K0.1%+2.4%1.149% 11/6/2024 Signature Estate & Investment Advisors LLC47,328$90K0.0%N/A0.132% 8/9/2024 Renaissance Technologies LLC57,600$106K0.0%-23.1%0.161% 5/20/2024 Virtu Financial LLC22,040$37K0.0%N/A0.000% 2/14/2023 RA Capital Management L.P.295,966$216K0.0%-85.8%1.028% 11/14/2022 RA Capital Management L.P.2,082,372$2.17M0.0%-11.5%7.229% 1/31/2022Altium Wealth Management LLC11,830$33K0.0%N/A0.050% 1/28/2022 ARK Investment Management LLC690,922$1.95M0.0%+1.2%2.915% 8/17/2021 Knoll Capital Management LLC2,484,275$14.86M7.8%+38.7%10.482% 8/16/2021 RA Capital Management L.P.2,353,000$14.07M0.2%N/A9.928% 8/13/2021 Geode Capital Management LLC17,597$105K0.0%N/A0.074% 8/11/2021 Susquehanna Fundamental Investments LLC14,400$86K0.0%N/A0.061% 6/14/2021 Knoll Capital Management LLC1,791,363$6.83M4.4%+2.9%7.558% 5/18/2021 Millennium Management LLC38,611$147K0.0%N/A0.163% 5/14/2021 XTX Topco Ltd11,559$44K0.0%N/A0.101% 5/13/2021 Renaissance Technologies LLC120,407$459K0.0%+66.8%1.053% (Data available from 1/1/2016 forward) ENTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ENTX shares? During the previous two years, 9 institutional investors and hedge funds held shares of Entera Bio. The most heavily invested institutionals were Knoll Capital Management LLC ($12.47M), Schonfeld Strategic Advisors LLC ($1.34M), Parkman Healthcare Partners LLC ($747K), Northern Trust Corp ($450K), Perigon Wealth Management LLC ($325K), Renaissance Technologies LLC ($106K), and Signature Estate & Investment Advisors LLC ($90K).Learn more on ENTX's institutional investors. What percentage of Entera Bio stock is owned by institutional investors? 14.11% of Entera Bio stock is owned by institutional investors. Learn more on ENTX's institutional investor holdings. Which institutional investors have been buying Entera Bio stock? The following institutional investors have purchased Entera Bio stock in the last 24 months: Knoll Capital Management LLC ($2M), Northern Trust Corp ($212.48K), Perigon Wealth Management LLC ($145.84K), Signature Estate & Investment Advisors LLC ($47.33K), Parkman Healthcare Partners LLC ($35.46K), Virtu Financial LLC ($22.04K), and HighTower Advisors LLC ($6.31K). How much institutional buying is happening at Entera Bio? Institutional investors have bought a total of 2,469,462 shares in the last 24 months. This purchase volume represents approximately $5.20M in transactions. Which Entera Bio major shareholders have been selling company stock? The following institutional investors have sold Entera Bio stock in the last 24 months: Renaissance Technologies LLC ($17.30K), and Schonfeld Strategic Advisors LLC ($16.29K). How much institutional selling is happening at Entera Bio? Institutional investors have sold a total of 33,589 shares in the last 24 months. This volume of shares sold represents approximately $66.36K in transactions. Related Companies Verve Therapeutics Institutional Ownership Tectonic Therapeutic Institutional Ownership ORIC Pharmaceuticals Institutional Ownership Rapport Therapeutics Institutional Ownership Revance Therapeutics Institutional Ownership Organogenesis Institutional Ownership Alpha Teknova Institutional Ownership MBX Biosciences Institutional Ownership Oruka Therapeutics Institutional Ownership COMPASS Pathways Institutional Ownership This page (NASDAQ:ENTX) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entera Bio Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entera Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ENTX Stock Free ENTX Stock Alerts